Abstract:Objective To study the effect of melatonin on the expression of microRNA-9 (miRNA,miR-9) and the mechanism of melatonin reducing the inflammation in sepsis as well as the key role of miR-9 in inhibiting the inflammatory reaction in sepsis.Methods Sepsis mouse models were prepared and randomly divided into sepsis model group [lipopolysaccharide (LPS) group] and sepsis melatonin treatment group (Mel + LPS group).Melatonin (30 mg/kg,Mel + LPS group) or same volume of saline (Mel + LPS group) was administered half hour before LPS injection,at the same time of LPS injection and four hours after LPS injection intraperitoneally.Half of the mice were killed and blood was collected after 24 h.Remaining mice were killed 48 hours later.Tissues of liver,lung were collected and the pathological changes of the tissues were observed through hematoxylin and eosin (HE) staining.Protein levels of tumor necrosis factors (TNF)-α and interleukin (IL)-1β in serum were detected by enzyme-linked immunosorbent assay (ELISA) levels of miR-9 in lung and liver were detected by real-time fluorescent quantitative polymerase chain reaction (FQ-PCR).RAW264.7 macrophages were divided into control inhibitor group (NC group),miR-9 inhibitor group (miR-9-in group),LPS + control inhibitor group (LPS + NC group) and LPS + miR-9 inhibitor group (LPS + miR-9-in group).Cells were transfected with miR-9 inhibitor,miR-9 inhibitor control section respectively.Levels of TNF-α and IL-1β were detected by FQ-PCR.Protein levels of p65 and p-p65 were detected by Western blotting.Results HE staining showed that organs in LPS group had severe damage and inflammatory cells infiltration.The degree of organ damage in Mel + LPS group was significantly improved compared with that in LPS group.Levels of TNF-α and IL-1β in Mel + LPS group were significantly decreased [TNF-α:(93.17 ± 21.92) ng/L vs.(236.83± 24.86) ng/L;IL-1β:(97.07± 14.62) ng/L vs.(159.63± 28.83) ng/L,P ＜0.01].In Mel + LPS group,levels of miR-9 in lung and liver were significantly decreased compared with those in LPS group (lung:0.61 ± 0.12 vs.2.36 ± 0.13;liver:0.62 ± 0.19 vs.2.85 ± 0.57,P ＜ 0.01).In macrophage,the levels of TNF-α,IL-13 in LPS + miR-9-in group significantly decreased (TNF-α:21.92 ± 3.67 vs.42.94 ± 8.88;IL-13:351.55 ± 71.89 vs.645.00 ± 55.02,P ＜ 0.01).The phosphorylated-p65 protein level was also decreased in LPS + miR-9-in group (0.14 ± 0.05 vs.0.67 ± 0.11,P ＜ 0.01).Conclusion Melatonin could inhibit the activation of the nuclear factor-κB (NF-κB) pathway by decreasing the level of miR-9,and finally suppress inflammation and organ damage in sepsis

Melatonin attenuates sepsis-induced cardiac dysfunction via a PI3K/Akt-dependent mechanism

Melatonin Attenuates Sepsis-Induced Muscle Atrophy by Regulating the PI3K/Akt Signaling Pathway

Melatonin Alleviates Cardiac Dysfunction Via Increasing Sirt1-Mediated Beclin-1 Deacetylation and Autophagy During Sepsis

Melatonin improved rat cardiac mitochondria and survival rate in septic heart injury

Melatonin alleviates sepsis-induced heart injury through activating the Nrf2 pathway and inhibiting the NLRP3 inflammasome

Melatonin alleviates brain injury in mice subjected to cecal ligation and puncture via attenuating inflammation, apoptosis, and oxidative stress: the role of SIRT1 signaling

Melatonin ameliorates myocardial injury by reducing apoptosis and autophagy of cardiomyocytes in a rat cardiopulmonary bypass model

Therapeutic contribution of melatonin to the treatment of septic cardiomyopathy: A novel mechanism linking Ripk3-modified mitochondrial performance and endoplasmic reticulum function

Melatonin Reduces PERK-eIF2α-ATF4-mediated Endoplasmic Reticulum Stress During Myocardial Ischemia–reperfusion Injury: Role of RISK and SAFE Pathways Interaction

Protective Effects of Melatonin on Sepsis-Induced Liver Injury and Dysregulation of Gluconeogenesis in Rats Through Activating SIRT1/STAT3 Pathway.

Short- and Long-Term Protective Effects of Melatonin in a Mouse Model of Sepsis-Associated Encephalopathy

Melatonin Attenuates Sepsis-Induced Small-Intestine Injury by Upregulating SIRT3-Mediated Oxidative-Stress Inhibition, Mitochondrial Protection, and Autophagy Induction

Melatonin: A potential protective multifaceted force for sepsis-induced cardiomyopathy

The Protective Effects of Melatonin Against LPS-Induced Septic Myocardial Injury: A Potential Role of AMPK-Mediated Autophagy

Cardiac-targeted delivery of nuclear receptor RORα via ultrasound targeted microbubble destruction optimizes the benefits of regular dose of melatonin on sepsis-induced cardiomyopathy

Melatonin Attenuates Sepsis-Induced Acute Lung Injury Through Improvement of Epithelial Sodium Channel-Mediated Alveolar Fluid Clearance Via Activation of SIRT1/SGK1/Nedd4-2 Signaling Pathway

Melatonin attenuates sepsis-induced acute kidney injury by promoting mitophagy through SIRT3-mediated TFAM deacetylation

Melatonin attenuates ER stress and mitochondrial damage in septic cardiomyopathy: A new mechanism involving BAP31 upregulation and MAPK‐ERK pathway

Melatonin Mediates Cardiac Tissue Damage under Septic Conditions Induced by Lipopolysaccharide

Melatonin regulates inflammation in sepsis via microRNA-9 and related mechanism

A novel mechanism for the protection against acute lung injury by melatonin: mitochondrial quality control of lung epithelial cells is preserved through SIRT3-dependent deacetylation of SOD2